Founded by Alex Voda and Alex Bacita, the Bucharest-based biotech uses in silico modeling and machine learning to identify drug targets for age-related disease in cats. It runs a collaboration with diagnostics company EpiPaws on a 100-cat omics study. Headquartered in Bucharest.